IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $8,000 | -92.5% | 200 | -91.5% | 0.00% | -100.0% |
| Q1 2021 | $106,000 | +863.6% | 2,350 | +1075.0% | 0.00% | – |
| Q4 2020 | $11,000 | -35.3% | 200 | -44.4% | 0.00% | – |
| Q1 2020 | $17,000 | -48.5% | 360 | -33.8% | 0.00% | – |
| Q4 2019 | $33,000 | 0.0% | 544 | -1.1% | 0.00% | – |
| Q3 2019 | $33,000 | +37.5% | 550 | +48.2% | 0.00% | – |
| Q2 2019 | $24,000 | -4.0% | 371 | +21.6% | 0.00% | – |
| Q1 2019 | $25,000 | +150.0% | 305 | +67.6% | 0.00% | – |
| Q4 2018 | $10,000 | +11.1% | 182 | 0.0% | 0.00% | – |
| Q3 2018 | $9,000 | +12.5% | 182 | 0.0% | 0.00% | – |
| Q2 2018 | $8,000 | 0.0% | 182 | 0.0% | 0.00% | – |
| Q1 2018 | $8,000 | -42.9% | 182 | -34.3% | 0.00% | – |
| Q4 2017 | $14,000 | +55.6% | 277 | +52.2% | 0.00% | – |
| Q3 2017 | $9,000 | 0.0% | 182 | 0.0% | 0.00% | – |
| Q2 2017 | $9,000 | – | 182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |